Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02193295 · ClinicalTrials.gov registry record · NA
Reversal of Lipid-Induced Insulin Resistance
A NA study of Insulin Resistance and NAFLD, sponsored by Yale University.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 2
- Study locations
NCT02193295 is a NA study of Insulin Resistance and NAFLD that is actively recruiting participants, run by Yale University. The registered enrollment target is 250 participants, roughly in line with the 243-participant average among 120 other Insulin Resistance trials with a reported enrollment target. The trial reports 2 study locations across 1 state.
The verdict
NCT02193295, a NA study of Insulin Resistance and NAFLD, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to examine whether weight reduction decreases intramyocellular (IMCL) and hepatic lipid content, and improves insulin sensitivity of muscle and fat tissue in people who are insulin resistant and have a family history of type 2 diabetes. Hepatic mitochondrial oxidation will be assesses using a 3 hour triple tracer study (D7 glucose, 3-13C lactate and 13C4 beta-hydroxybutyrate).
Conditions Studied
Interventions
- BEHAVIORAL Caloric Restriction
Study Locations (2)
Connecticut
- Magnetic Resonance Research Center (MRRC) - New Haven
- Yale Center for Clinical Investigation HRU - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2002-10 |
| Est. Completion | 2034-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02193295
The ClinicalTrials.gov registry entry for NCT02193295 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 243-participant average among 120 other Insulin Resistance trials with a reported enrollment target. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Insulin Resistance appearing as the primary indexed condition, and to 1 intervention - of which Caloric Restriction is the first listed.
NCT02193295 reports 2 study locations spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT02193295 about?
NCT02193295 is a clinical study titled "Reversal of Lipid-Induced Insulin Resistance". The purpose of this study is to examine whether weight reduction decreases intramyocellular (IMCL) and hepatic lipid content, and improves insulin sensitivity of muscle and fat tissue in people who are insulin resistant and have a family history of type 2 diabetes. Hepatic mitochondrial oxidation w...
What is the current status of trial NCT02193295?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2002-10. Estimated completion is 2034-12.
What conditions does trial NCT02193295 study?
This clinical trial studies the following conditions: Insulin Resistance, NAFLD.
What interventions are being tested in trial NCT02193295?
The interventions under investigation include: Caloric Restriction (BEHAVIORAL).
Who is sponsoring clinical trial NCT02193295?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02193295 being conducted?
This trial has 2 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insulin Resistance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
RECRUITING · NA
-
Small Extracellular Vesicles and Insulin Action
RECRUITING · NA
-
Exercise Effects on Adipose Tissue Structure and Function
RECRUITING · NA
-
New Mechanisms of Obesity
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.